Skip to content

Research & Literature

Last updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 133 referenced papers

Top Authors

Top Institutions

References

  1. 1

    Contrast-enhanced MRI features in the early diagnosis of Juvenile Idiopathic Arthritis.

    Hemke R, Kuijpers TW, Nusman CM, et al.

    European radiology 2015; (25(11)):3222-9 doi:10.1007/s00330-015-3752-x.

    PMID: 26002127
  2. 2

    Treatment in juvenile rheumatoid arthritis and new treatment options.

    Kasapçopur Ö, Barut K

    Turk pediatri arsivi 2015; (50(1)):1-10 doi:10.5152/tpa.2015.2229.

    PMID: 26078691
  3. 3

    Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.

    Wagner-Weiner L

    Pediatric annals 2015; (44(6)):e142-7 doi:10.3928/00904481-20150611-09.

    PMID: 26114369
  4. 4

    Imbalance of Th17 and T-regulatory cells in peripheral blood and synovial fluid in treatment naïve children with juvenile idiopathic arthritis.

    Szymańska-Kałuża J, Cebula-Obrzut B, Smolewski P, et al.

    Central-European journal of immunology 2014; (39(1)):71-6 doi:10.5114/ceji.2014.42128.

    PMID: 26155103
  5. 5

    2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

    Ravelli A, Minoia F, Davì S, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2016; (68(3)):566-76 doi:10.1002/art.39332.

    PMID: 26314788
  6. 6

    Macrophage Activation Syndrome.

    Sen ES, Clarke SL, Ramanan AV

    Indian journal of pediatrics 2016; (83(3)):248-53 doi:10.1007/s12098-015-1877-1.

    PMID: 26400031
  7. 7

    [Biomarkers for chronic inflammatory diseases].

    Holzinger D, Föll D

    Zeitschrift fur Rheumatologie 2015; (74(10)):887-96; quiz 897 doi:10.1007/s00393-015-0009-7.

    PMID: 26608264
  8. 8

    Is early TMJ involvement in children with juvenile idiopathic arthritis clinically detectable? Clinical examination of the TMJ in comparison with contrast enhanced MRI in patients with juvenile idiopathic arthritis.

    Keller H, Müller LM, Markic G, et al.

    Pediatric rheumatology online journal 2015; (13()):56 doi:10.1186/s12969-015-0056-2.

    PMID: 26646650
  9. 9

    Current Treatment Modalities of JIA-associated Uveitis and its Complications: Literature Review.

    Abu Samra K, Maghsoudlou A, Roohipoor R, et al.

    Ocular immunology and inflammation 2016; (24(4)):431-9 doi:10.3109/09273948.2015.1115878.

    PMID: 26765345
  10. 10

    The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.

    Shepherd J, Cooper K, Harris P, et al.

    Health technology assessment (Winchester, England) 2016; (20(34)):1-222 doi:10.3310/hta20340.

    PMID: 27135404
  11. 11

    Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis.

    Żuber Z, Turowska-Heydel D, Sobczyk M, et al.

    Reumatologia 2016; (54(1)):19-23 doi:10.5114/reum.2016.58757.

    PMID: 27407272
  12. 12

    Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis.

    Jain D, Aggarwal HK, Rao A, et al.

    Reumatologia 2016; (54(1)):42-7 doi:10.5114/reum.2016.58763.

    PMID: 27407277
  13. 13

    Tocilizumab in the treatment of systemic juvenile idiopathic arthritis.

    Murakami M, Tomiita M, Nishimoto N

    Open access rheumatology : research and reviews 2012; (4()):71-79 doi:10.2147/OARRR.S21969.

    PMID: 27790014
  14. 14

    Implementation of musculoskeletal ultrasonography in detection of early juvenile idiopathic arthritis.

    Darwish AF, Ismael FM, Ell-Laban A, et al.

    European journal of radiology open 2016; (3()):264-271 doi:10.1016/j.ejro.2016.11.001.

    PMID: 27900348
  15. 15

    Imaging in paediatric rheumatology: Is it time for imaging?

    Collado P, Malattia C

    Best practice & research. Clinical rheumatology 2016; (30(4)):720-735 doi:10.1016/j.berh.2016.08.009.

    PMID: 27931964
  16. 16

    Secretion of pro-inflammatory cytokines and chemokines and loss of regulatory signals by fibroblast-like synoviocytes in juvenile idiopathic arthritis.

    Brescia AC, Simonds MM, Sullivan KE, Rose CD

    Proteomics. Clinical applications 2017; (11(5-6)) doi:10.1002/prca.201600088.

    PMID: 28012239
  17. 17

    A better understanding of juvenile idiopathic arthritis with classification criteria.

    Akioka S

    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2016; (39(6)):513-521 doi:10.2177/jsci.39.513.

    PMID: 28049960
  18. 18

    Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis.

    Sarkar S, Alam MM, Das G, Datta S

    Indian journal of pediatrics 2017; (84(5)):349-356 doi:10.1007/s12098-017-2292-6.

    PMID: 28176230
  19. 19

    Sonography for the investigation of a child with a limp.

    Crow A, Cheung A, Lam A, Ho E

    Australasian journal of ultrasound in medicine 2010; (13(3)):23-30 doi:10.1002/j.2205-0140.2010.tb00160.x.

    PMID: 28191087
  20. 20

    Differential diagnosis of septic hip arthritis in childhood by ultrasound examination.

    Konermann W, Gruber G

    Der Orthopade 1997; (26(10)):830-837 doi:10.1007/PL00003332.

    PMID: 28246857
  21. 21

    MR Imaging of the Temporomandibular Joint in Juvenile Idiopathic Arthritis: Technique and Findings.

    Navallas M, Inarejos EJ, Iglesias E, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2017; (37(2)):595-612 doi:10.1148/rg.2017160078.

    PMID: 28287946
  22. 22

    The novel use of combined IL-1 and IL-6 inhibition in a patient with severe, aggressive, erosive, systemic-onset juvenile idiopathic arthritis.

    Lee M, Isaacs J

    European journal of rheumatology 2017; (4(1)):68-69 doi:10.5152/eurjrheum.2016.055.

    PMID: 28293458
  23. 23

    A study on the physical fitness of children with juvenile rheumatoid arthritis.

    Kwon HJ, Kim YL, Lee HS, Lee SM

    Journal of physical therapy science 2017; (29(3)):378-383 doi:10.1589/jpts.29.378.

    PMID: 28356614
  24. 24

    Characteristics and Course of Enthesitis in a Juvenile Idiopathic Arthritis Inception Cohort.

    Rumsey DG, Guzman J, Rosenberg AM, et al.

    Arthritis care & research 2018; (70(2)):303-308 doi:10.1002/acr.23256.

    PMID: 28426894
  25. 25

    When a patient suspected with juvenile idiopathic arthritis turns out to be diagnosed with an infectious disease - a review of Lyme arthritis in children.

    Orczyk K, Świdrowska-Jaros J, Smolewska E

    Pediatric rheumatology online journal 2017; (15(1)):35 doi:10.1186/s12969-017-0166-0.

    PMID: 28482848
  26. 26

    Biologics in juvenile idiopathic arthritis: a narrative review.

    Vanoni F, Minoia F, Malattia C

    European journal of pediatrics 2017; (176(9)):1147-1153 doi:10.1007/s00431-017-2960-6.

    PMID: 28725955
  27. 27

    Peptide-based electrochemical biosensor for juvenile idiopathic arthritis detection.

    Rodovalho VR, Araujo GR, Vaz ER, et al.

    Biosensors & bioelectronics 2018; (100()):577-582 doi:10.1016/j.bios.2017.10.012.

    PMID: 29031228
  28. 28

    Flares of Disease in Children with Clinically Inactive Juvenile Idiopathic Arthritis Were Not Correlated with Ultrasound Findings.

    Zhao Y, Rascoff NE, Iyer RS, et al.

    The Journal of rheumatology 2018; (45(6)):851-857 doi:10.3899/jrheum.170681.

    PMID: 29606669
  29. 29

    [JUVENILE IDIOPATHIC ARTHRITIS].

    Bukovac LT, Perica M

    Reumatizam 2016; (63 Suppl 1()):53-8.

    PMID: 29624302
  30. 30

    Treating juvenile idiopathic arthritis to target: recommendations of an international task force.

    Ravelli A, Consolaro A, Horneff G, et al.

    Annals of the rheumatic diseases 2018; (77(6)):819-828 doi:10.1136/annrheumdis-2018-213030.

    PMID: 29643108
  31. 31

    Juvenile idiopathic arthritis-associated uveitis.

    Sen ES, Ramanan AV

    Best practice & research. Clinical rheumatology 2017; (31(4)):517-534 doi:10.1016/j.berh.2018.01.002.

    PMID: 29773271
  32. 32

    Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual Meeting.

    Zisman D, Stoll ML, Butbul Aviel Y, Mellins ED

    The Journal of rheumatology. Supplement 2018; (94()):11-16 doi:10.3899/jrheum.180131.

    PMID: 29858347
  33. 33

    Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.

    Ferrara G, Mastrangelo G, Barone P, et al.

    Pediatric rheumatology online journal 2018; (16(1)):46 doi:10.1186/s12969-018-0255-8.

    PMID: 29996864
  34. 34

    Juvenile Idiopathic Arthritis: Oligoarthritis and Polyarthritis.

    Crayne CB, Beukelman T

    Pediatric clinics of North America 2018; (65(4)):657-674 doi:10.1016/j.pcl.2018.03.005.

    PMID: 30031492
  35. 35

    Temporomandibular joint involvement in children with juvenile idiopathic arthritis: a preliminary report.

    Abramowicz S, Levy JM, Prahalad S, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2019; (127(1)):19-23 doi:10.1016/j.oooo.2018.07.008.

    PMID: 30126808
  36. 36

    Heterogeneous Knee Effusions on Point-of-Care Ultrasound in a Toddler Diagnosed With Juvenile Idiopathic Arthritis.

    Rizvi MB, Rabiner JE

    Pediatric emergency care 2018; (34(9)):673-675 doi:10.1097/PEC.0000000000001610.

    PMID: 30180103
  37. 37

    Temporomandibular joint disorders as the only manifestation of juvenile idiopathic arthritis: a case report.

    Pinto JRR, Pedron IG, Utumi ER, et al.

    Einstein (Sao Paulo, Brazil) 2018; (16(3)):eRC4003 doi:10.1590/S1679-45082018RC4003.

    PMID: 30208154
  38. 38

    Glucocorticoid treatment in juvenile idiopathic arthritis.

    Batu ED

    Rheumatology international 2019; (39(1)):13-27 doi:10.1007/s00296-018-4168-0.

    PMID: 30276425
  39. 39

    Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.

    Lee JJY, Duffy CM, Guzman J, et al.

    Arthritis care & research 2019; (71(11)):1436-1443 doi:10.1002/acr.23783.

    PMID: 30320957
  40. 40

    Classifications and imaging of juvenile spondyloarthritis.

    Sudoł-Szopińska I, Eshed I, Jans L, et al.

    Journal of ultrasonography 2018; (18(74)):224-233 doi:10.15557/JoU.2018.0033.

    PMID: 30451405
  41. 41

    Features distinguishing juvenile idiopathic arthritis among children with musculoskeletal complaints.

    Jeamsripong S, Charuvanij S

    World journal of pediatrics : WJP 2020; (16(1)):74-81 doi:10.1007/s12519-018-0212-0.

    PMID: 30498888
  42. 42

    Association of hand grip strength with disease activity, disability and quality of life in children and adolescents with Juvenile Idiopathic Arthritis.

    Rashed AM, Abdel-Wahab N, Moussa EMM, Hammam N

    Advances in rheumatology (London, England) 2018; (58(1)):11 doi:10.1186/s42358-018-0012-1.

    PMID: 30657067
  43. 43

    Noninflammatory disorders mimic juvenile idiopathic arthritis.

    Al-Mayouf SM

    International journal of pediatrics & adolescent medicine 2018; (5(1)):1-4 doi:10.1016/j.ijpam.2018.01.004.

    PMID: 30805524
  44. 44

    [Juvenile idiopathic arthritis].

    A Aeschlimann F, Quartier P

    La Revue du praticien 2019; (69(2)):188-194.

    PMID: 30983224
  45. 45

    A case of acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis.

    Demir F, Eroglu N, Bahadir A, Kalyoncu M

    Northern clinics of Istanbul 2019; (6(2)):184-188 doi:10.14744/nci.2018.48658.

    PMID: 31297487
  46. 46

    Study of role of serum amyloid A (SAA) as a marker of disease activity in juvenile idiopathic arthritis.

    Dev S, Singh A

    Journal of family medicine and primary care 2019; (8(6)):2129-2133 doi:10.4103/jfmpc.jfmpc_339_19.

    PMID: 31334192
  47. 47

    The Utility and Experience with Disease Biomarkers in Juvenile Onset Arthritis vs. Adult Onset Arthritis.

    Patwardhan A

    Cureus 2019; (11(7)):e5131 doi:10.7759/cureus.5131.

    PMID: 31341750
  48. 48

    Frequency and Identification of Risk Factors of Uveitis in Juvenile Idiopathic Arthritis: A Long-term Follow-up Study in a Cohort of Italian Children.

    Conti G, Chirico V, Porcaro F, et al.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2020; (26(7)):285-288 doi:10.1097/RHU.0000000000001104.

    PMID: 31609817
  49. 49

    Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis.

    Nziza N, Jeziorski E, Delpont M, et al.

    Cells 2019; (8(12)) doi:10.3390/cells8121521.

    PMID: 31779271
  50. 50

    Juvenile idiopathic arthritis-associated uveitis.

    Sen ES, Ramanan AV

    Clinical immunology (Orlando, Fla.) 2020; (211()):108322 doi:10.1016/j.clim.2019.108322.

    PMID: 31830532
  51. 51

    Tumefactive synovial thickening mimicking synovial chondromatosis in the setting of oligoarticular juvenile idiopathic arthritis in a toddler.

    Rousslang LK, Rooks E, Hixson C, West P

    Radiology case reports 2020; (15(3)):218-221 doi:10.1016/j.radcr.2019.11.016.

    PMID: 31890072
  52. 52

    Determination of diagnostic value (validity) leukocyte esterase (urine dipstick strip) in differentiating inflammatory arthritis from bacterial arthritis.

    Hassas Yeganeh M, Talaei M, Bazzaz AE, et al.

    Advances in rheumatology (London, England) 2020; (60(1)):11 doi:10.1186/s42358-020-0115-3.

    PMID: 31992368
  53. 53

    Quantitative analysis of facial asymmetry based on three-dimensional photography: a valuable indicator for asymmetrical temporomandibular joint affection in juvenile idiopathic arthritis patients?

    Bernini JM, Kellenberger CJ, Eichenberger M, et al.

    Pediatric rheumatology online journal 2020; (18(1)):10 doi:10.1186/s12969-020-0401-y.

    PMID: 32005249
  54. 54

    Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis.

    Klein A, Minden K, Hospach A, et al.

    Annals of the rheumatic diseases 2020; (79(7)):969-974 doi:10.1136/annrheumdis-2019-216843.

    PMID: 32299797
  55. 55

    Intestinal microbiota and juvenile idiopathic arthritis: current understanding and future prospective.

    Xin L, He F, Li S, et al.

    World journal of pediatrics : WJP 2021; (17(1)):40-51 doi:10.1007/s12519-020-00371-3.

    PMID: 32533534
  56. 56

    Unexpected macrophage activation syndrome in a healthy young woman: a case report.

    Saviano A, Petrucci M, Tilli P, et al.

    European review for medical and pharmacological sciences 2020; (24(13)):7320-7323 doi:10.26355/eurrev_202007_21893.

    PMID: 32706070
  57. 57

    Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children.

    Brix N, Rosthøj S, Glerup M, et al.

    PloS one 2020; (15(8)):e0237530 doi:10.1371/journal.pone.0237530.

    PMID: 32780759
  58. 58

    Children with oligoarticular juvenile idiopathic arthritis have skewed synovial monocyte polarization pattern with functional impairment-a distinct inflammatory pattern for oligoarticular juvenile arthritis.

    Schmidt T, Berthold E, Arve-Butler S, et al.

    Arthritis research & therapy 2020; (22(1)):186 doi:10.1186/s13075-020-02279-9.

    PMID: 32787920
  59. 59

    Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study.

    Rypdal V, Glerup M, Songstad NT, et al.

    Ophthalmology 2021; (128(4)):598-608 doi:10.1016/j.ophtha.2020.08.024.

    PMID: 32866542
  60. 60

    Cumulative Damage in Juvenile Idiopathic Arthritis: A Multicenter Study From the Pediatric Rheumatology Arab Group.

    Al-Mayouf SM, Hashad S, Khawaja K, et al.

    Arthritis care & research 2021; (73(4)):586-592 doi:10.1002/acr.24436.

    PMID: 32886859
  61. 61

    Current Therapeutic Options for the Treatment of Juvenile Idiopathic Arthritis.

    Saougou IG, Markatseli TE, Voulgari PV, Drosos AA

    Current rheumatology reviews 2021; (17(1)):41-57 doi:10.2174/1573403X16999200917151805.

    PMID: 32942977
  62. 62

    Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis.

    Brunner HI, Wong R, Nys M, et al.

    Paediatric drugs 2020; (22(6)):653-672 doi:10.1007/s40272-020-00422-2.

    PMID: 33029724
  63. 63

    Juvenile idiopathic arthritis in a premature baby: rare case report.

    Doya LJ, Bijow FW, Dayoub A

    Oxford medical case reports 2020; (2020(11)):omaa100 doi:10.1093/omcr/omaa100.

    PMID: 33269084
  64. 64

    A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis.

    van Straalen JW, Giancane G, Amazrhar Y, et al.

    Rheumatology (Oxford, England) 2021; (60(6)):2896-2905 doi:10.1093/rheumatology/keaa733.

    PMID: 33274366
  65. 65

    [Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].

    Strickler AL, Cifuentes D, Mihovilovic K, et al.

    Revista chilena de pediatria 2020; (91(4)):521-528 doi:10.32641/rchped.v91i4.1376.

    PMID: 33399728
  66. 66

    The readiness of pediatric rheumatology patients and their parents to transition to adult-oriented treatment.

    Sönmez HE, Koç R, Karadağ ŞG, Aktay Ayaz N

    International journal of rheumatic diseases 2021; (24(3)):397-401 doi:10.1111/1756-185X.14050.

    PMID: 33452739
  67. 67

    14-3-3η Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis.

    Dalrymple A, Tuttle P, Feller L, et al.

    Pediatric reports 2021; (13(1)):65-71 doi:10.3390/pediatric13010008.

    PMID: 33504004
  68. 68

    Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry.

    Raab A, Kallinich T, Huscher D, et al.

    Pediatric rheumatology online journal 2021; (19(1)):41 doi:10.1186/s12969-021-00522-4.

    PMID: 33752685
  69. 69

    Features and Clinical Course of Infantile Juvenile Idiopathic Arthritis.

    Campbell JA, Shenoi S

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2022; (28(2)):e609-e611 doi:10.1097/RHU.0000000000001737.

    PMID: 33843769
  70. 70

    MR Imaging of Rheumatic Diseases Affecting the Pediatric Population.

    Schiettecatte E, Jans L, Jaremko JL, et al.

    Seminars in musculoskeletal radiology 2021; (25(1)):82-93 doi:10.1055/s-0041-1726435.

    PMID: 34020470
  71. 71

    Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.

    Kimura Y, Schanberg LE, Tomlinson GA, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2021; (73(10)):1898-1909 doi:10.1002/art.41888.

    PMID: 34105312
  72. 72

    Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.

    Davidson N, Rangarajan HG, Driest K, et al.

    Case reports in rheumatology 2021; (2021()):9323141 doi:10.1155/2021/9323141.

    PMID: 34123455
  73. 73

    Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage.

    Al-Mayouf SM, Alrasheedi A, Almsellati I, et al.

    International journal of rheumatic diseases 2021; (24(8)):1080-1085 doi:10.1111/1756-185X.14167.

    PMID: 34184820
  74. 74

    Assessment of transition readiness in adolescents in Thailand with rheumatic diseases: a cross-sectional study.

    Kittivisuit S, Lerkvaleekul B, Soponkanaporn S, et al.

    Pediatric rheumatology online journal 2021; (19(1)):101 doi:10.1186/s12969-021-00602-5.

    PMID: 34193176
  75. 75

    Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches.

    Quartier P

    Journal of clinical medicine 2021; (10(13)) doi:10.3390/jcm10132934.

    PMID: 34208973
  76. 76

    Mandibular range of motion in children with juvenile idiopathic arthritis with and without clinically established temporomandibular joint involvement and in healthy children; a cross-sectional study.

    de Sonnaville WFC, Speksnijder CM, Zuithoff NPA, et al.

    Pediatric rheumatology online journal 2021; (19(1)):106 doi:10.1186/s12969-021-00583-5.

    PMID: 34217306
  77. 77

    Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches.

    Zaripova LN, Midgley A, Christmas SE, et al.

    Pediatric rheumatology online journal 2021; (19(1)):135 doi:10.1186/s12969-021-00629-8.

    PMID: 34425842
  78. 78

    Patterns and rates of confirmed transfer of care of patients with juvenile idiopathic arthritis at a tertiary paediatric rheumatology centre.

    Tan J, Tiller G, Gowdie P, et al.

    Internal medicine journal 2023; (53(1)):46-50 doi:10.1111/imj.15509.

    PMID: 34498355
  79. 79

    Diagnosis and treatment of uveitis associated with juvenile idiopathic arthritis.

    Lazăr C, Spîrchez M, Ştefan M, et al.

    Medicine and pharmacy reports 2021; (94(Suppl No 1)):S28-S32 doi:10.15386/mpr-2224.

    PMID: 34527905
  80. 80

    [Still's syndrome-similarities and differences between the juvenile and adult forms].

    Regel A, Föll D, Kriegel MA

    Zeitschrift fur Rheumatologie 2022; (81(1)):22-27 doi:10.1007/s00393-021-01117-w.

    PMID: 34735597
  81. 81

    [Recommendations of diagnosis and treatment of juvenile idiopathic arthritis in China].

    Li CF, Huang YF, Wang ZH, et al.

    Zhonghua nei ke za zhi 2022; (61(2)):142-156 doi:10.3760/cma.j.cn112138-20210929-00666.

    PMID: 35090249
  82. 82

    Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.

    El Tal T, Ryan ME, Feldman BM, et al.

    The Journal of rheumatology 2022; (49(5)):497-503 doi:10.3899/jrheum.210709.

    PMID: 35105705
  83. 83

    Considerations for the Primary Care Provider Caring for Patients with Juvenile Idiopathic Arthritis Receiving Biologic Therapy.

    Zic C

    Pediatric annals 2022; (51(2)):e54-e56 doi:10.3928/19382359-20220118-02.

    PMID: 35156891
  84. 84

    Two-Staged Total Knee Arthroplasty in Juvenile Rheumatoid Arthritis with Severe Flexion Deformity: A Case Report.

    Vecham R, Annapareddy A, Hippalgaonkar K, et al.

    JBJS case connector 2022; (12(1)) doi:10.2106/JBJS.CC.21.00401.

    PMID: 35239551
  85. 85

    B Cells on the Stage of Inflammation in Juvenile Idiopathic Arthritis: Leading or Supporting Actors in Disease Pathogenesis?

    Moura RA, Fonseca JE

    Frontiers in medicine 2022; (9()):851532 doi:10.3389/fmed.2022.851532.

    PMID: 35449805
  86. 86

    [Biological therapy in juvenile idiopathic arthritis].

    Neve-Græsbøll A, Glerup M, Herlin T

    Ugeskrift for laeger 2022; (184(13)).

    PMID: 35499221
  87. 87

    Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis.

    Golhen K, Winskill C, Yeh C, et al.

    Frontiers in pediatrics 2022; (10()):909118 doi:10.3389/fped.2022.909118.

    PMID: 35799700
  88. 88

    Musculoskeletal pain and its effect on daily activity and behaviour in Icelandic children and youths with juvenile idiopathic arthritis: a cross-sectional case-control study.

    Oskarsdottir SA, Kristjansdottir A, Gudmundsdottir JA, et al.

    Pediatric rheumatology online journal 2022; (20(1)):48 doi:10.1186/s12969-022-00706-6.

    PMID: 35841034
  89. 89

    Can ultrasound help to overcome uncertainty in clinical joint assessment in juvenile idiopathic arthritis?

    Fingerhutová Š, Srp R, Hurňáková J, et al.

    Clinical and experimental rheumatology 2023; (41(1)):177-185 doi:10.55563/clinexprheumatol/5lk4x2.

    PMID: 35930492
  90. 90

    Anterior and posterior uveitis associated with juvenile idiopathic arthritis -case report.

    Petrescu L, Crișan M, Lazăr C, Stan C

    Romanian journal of ophthalmology 2022; (66(2)):185-190 doi:10.22336/rjo.2022.36.

    PMID: 35935079
  91. 91

    Development and External Validation of a Model Predicting New-Onset Chronic Uveitis at Different Disease Durations in Juvenile Idiopathic Arthritis.

    van Straalen JW, Kearsley-Fleet L, Klotsche J, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2023; (75(2)):318-327 doi:10.1002/art.42329.

    PMID: 36054539
  92. 92

    The Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment.

    Paroli M, Spadea L, Caccavale R, et al.

    Medicina (Kaunas, Lithuania) 2022; (58(11)) doi:10.3390/medicina58111552.

    PMID: 36363508
  93. 93

    Effectiveness of Early Physical Therapy Rehabilitation in Patient With Juvenile Rheumatoid Arthritis.

    Meghe S, Chitale N, Phansopkar P, Joshi A

    Cureus 2022; (14(10)):e30213 doi:10.7759/cureus.30213.

    PMID: 36381930
  94. 94

    Transition readiness in adolescents with juvenile idiopathic arthritis and their parents: Our single-center experience.

    Lazarević D, Đorđević S, Novaković D, et al.

    Archives of rheumatology 2022; (37(3)):411-416 doi:10.46497/ArchRheumatol.2022.9219.

    PMID: 36589608
  95. 95

    Contribution of Ultrasound in Current Practice for Managing Juvenile Idiopathic Arthritis.

    Borocco C, Anselmi F, Rossi-Semerano L

    Journal of clinical medicine 2022; (12(1)) doi:10.3390/jcm12010091.

    PMID: 36614888
  96. 96

    Association of HLA-B27 antigen with clinical and laboratory parameters in patients with juvenile idiopathic arthritis.

    Čengić A, Selmanović V, Hasanbegović S, et al.

    Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina 2023; (20(1)) doi:10.17392/1556-22.

    PMID: 36692982
  97. 97

    The Importance of Differentiating Oligoarticular Juvenile Idiopathic Arthritis From Lyme Arthritis in Pediatric Patients.

    Jeelani W, Harhay R, Wrotniak BH, et al.

    Cureus 2022; (14(12)):e32785 doi:10.7759/cureus.32785.

    PMID: 36694509
  98. 98

    MRI of the temporomandibular joint in children with juvenile idiopathic arthritis: protocol and findings.

    Inarejos Clemente EJ, Tolend M, Navallas M, et al.

    Pediatric radiology 2023; (53(8)):1498-1512 doi:10.1007/s00247-023-05616-7.

    PMID: 36944679
  99. 99

    The role of ultrasonography in assessing remission in juvenile idiopathic arthritis: a systematic review.

    Saoussen M, Yasmine M, Hiba B, et al.

    European journal of pediatrics 2023; (182(7)):2989-2997 doi:10.1007/s00431-023-04956-8.

    PMID: 37117764
  100. 100

    Differences between leukemic arthritis and juvenile idiopathic arthritis.

    Torres Jimenez AR, Solis Vallejo E, Cespedes Cruz AI, et al.

    Pediatric rheumatology online journal 2023; (21(1)):50 doi:10.1186/s12969-023-00836-5.

    PMID: 37259088
  101. 101

    Juvenile idiopathic arthritis and its associated uveitis.

    Maleki A, Patel PD, Foster CS

    Expert review of clinical immunology 2023; (19(9)):1157-1169 doi:10.1080/1744666X.2023.2231154.

    PMID: 37401872
  102. 102

    Treat-to-Target in Pediatric Rheumatic Diseases.

    Rosina S, Rebollo-Giménez AI, Consolaro A, Ravelli A

    Current rheumatology reports 2023; (25(11)):226-235 doi:10.1007/s11926-023-01112-x.

    PMID: 37584859
  103. 103

    A Young Adult Patient with Rheumatoid Disorder Presents for the Evaluation of Limited Mouth Opening.

    Aldosary SN, Tanaka TI

    Dental clinics of North America 2023; (67(4)):633-635 doi:10.1016/j.cden.2023.05.035.

    PMID: 37714612
  104. 104

    Advances in the Diagnosis and Treatment of Enthesitis-Related Arthritis.

    Di Gennaro S, Di Matteo G, Stornaiuolo G, et al.

    Children (Basel, Switzerland) 2023; (10(10)) doi:10.3390/children10101647.

    PMID: 37892310
  105. 105

    Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?

    Batu ED, Sener S, Balık Z, et al.

    Clinical rheumatology 2024; (43(1)):415-421 doi:10.1007/s10067-023-06828-w.

    PMID: 38012469
  106. 106

    [Protocols in pediatric rheumatology (PROKIND): treat-to-target in polyarticular juvenile idiopathic arthritis].

    Horneff G, Minden K, Foell D, et al.

    Zeitschrift fur Rheumatologie 2024; (83(1)):15-27 doi:10.1007/s00393-023-01452-0.

    PMID: 38157052
  107. 107

    Juvenile Idiopathic Arthritis.

    Sudhakar M, Kumar S

    Indian journal of pediatrics 2024; (91(9)):949-958 doi:10.1007/s12098-023-04939-5.

    PMID: 38163829
  108. 108

    Biotechnological therapeutic in Juvenile Idiopathic Arthritis: Pathophysiological implications and targeted therapies.

    Pinto AM, Ascenção I, Rodrigues M, Brito I

    ARP rheumatology 2023; (2(4)):299-306.

    PMID: 38174749
  109. 109

    Choice and switch of biologic drugs in juvenile idiopathic arthritis.

    Şener S, Başaran Ö, Batu ED, et al.

    The Turkish journal of pediatrics 2023; (65(6)):980-989.

    PMID: 38204313
  110. 110

    Long-term follow-up of 109 children with juvenile idiopathic oligoarthritis after first intra-articular corticosteroid injection.

    Zajc Avramovič M, Toplak N, Markelj G, et al.

    Arthritis research & therapy 2024; (26(1)):69 doi:10.1186/s13075-024-03303-y.

    PMID: 38486285
  111. 111

    Heterogeneity of macrophage activation syndrome and treatment progression.

    Dong Y, Wang T, Wu H

    Frontiers in immunology 2024; (15()):1389710 doi:10.3389/fimmu.2024.1389710.

    PMID: 38736876
  112. 112

    Pre-Rheumatology Referral Consultation and Investigation Pattern in Children with Joint Complaints: Focus on Juvenile Idiopathic Arthritis.

    Marino A, Baldassarre P, Ferrigno C, et al.

    Children (Basel, Switzerland) 2024; (11(5)) doi:10.3390/children11050600.

    PMID: 38790595
  113. 113

    Rheum for Improvement? Delayed Diagnosis of Juvenile Idiopathic Arthritis: A Narrative Review.

    Costello A, Rasooly I, Weiss P

    Arthritis care & research 2025; (77(3)):283-290 doi:10.1002/acr.25438.

    PMID: 39308000
  114. 114

    Evolution of treatment options for juvenile idiopathic arthritis.

    Ren T, Guan JH, Li Y, et al.

    World journal of orthopedics 2024; (15(9)):831-835 doi:10.5312/wjo.v15.i9.831.

    PMID: 39318493
  115. 115

    Identification and validation of susceptibility modules and hub genes in polyarticular juvenile idiopathic arthritis using WGCNA and machine learning.

    Liu J, Fan J, Duan H, et al.

    Autoimmunity 2025; (58(1)):2437239 doi:10.1080/08916934.2024.2437239.

    PMID: 39699225
  116. 116

    Synovial Fluid Markers and Extracellular Vesicles in Rheumatoid Arthritis.

    Smolinska V, Klimova D, Danisovic L, Harsanyi S

    Medicina (Kaunas, Lithuania) 2024; (60(12)) doi:10.3390/medicina60121945.

    PMID: 39768826
  117. 117

    Efficacy and safety of ibuprofen and naproxen in the treatment of oligoarticular juvenile idiopathic arthritis: bi-national cohort study.

    Ohana O, Marmor I, Ferguson R, et al.

    Immunopharmacology and immunotoxicology 2025; (47(2)):141-146 doi:10.1080/08923973.2024.2421523.

    PMID: 39789705
  118. 118

    [Juvenile idiopathic arthritis-Diagnosis and management].

    Brück N, Reiser C, Oommen PT, Welzel T

    Zeitschrift fur Rheumatologie 2025; (84(2)):140-151 doi:10.1007/s00393-025-01626-y.

    PMID: 39961862
  119. 119

    Management of patients with juvenile idiopathic arthritis in the emergency department.

    Cherian J

    Pediatric emergency medicine practice 2025; (22(3)):1-20.

    PMID: 39977851
  120. 120

    Clinical remission rate and drug withdrawal status in articular juvenile idiopathic arthritis.

    Oshima A, Ebato T, Kaneko M, et al.

    Pediatric rheumatology online journal 2025; (23(1)):21 doi:10.1186/s12969-025-01075-6.

    PMID: 39994731
  121. 121

    Characterization of Patients with Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis.

    Rogowska J, Kubicka J, Grabowska M, et al.

    Clinical rheumatology 2025; (44(5)):2023-2029 doi:10.1007/s10067-025-07420-0.

    PMID: 40146446
  122. 122

    Three-Year Outcomes and Latent Class Trajectory Analysis of the Childhood Arthritis and Rheumatology Research Alliance Polyarticular JIA Consensus Treatment Plans Study.

    Ringold S, Ong MS, Tomlinson G, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2025; (77(10)):1433-1441 doi:10.1002/art.43216.

    PMID: 40344490
  123. 123

    Intolerance of oral methotrexate in juvenile idiopathic arthritis.

    Yuda A, Nozawa T, Hattori S, et al.

    Pediatrics international : official journal of the Japan Pediatric Society 2025; (67(1)):e70112 doi:10.1111/ped.70112.

    PMID: 40539404
  124. 124

    French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease.

    Quartier P, Belot A, Breton S, et al.

    La Revue de medecine interne 2025; (46(8)):449-481 doi:10.1016/j.revmed.2025.06.001.

    PMID: 40544011
  125. 125

    [Non systemic forms of juvenile idiopathic arthristis].

    Felix A, Dumaine C, Meinzer U

    La Revue du praticien 2024; (74(10)):1082-1089.

    PMID: 40546197
  126. 126

    Clinical use of biologics in juvenile idiopathic arthritis: lessons learned from real-world studies.

    Atamyıldız Uçar S, Sözeri B

    Expert opinion on biological therapy 2025; (25(8)):835-846 doi:10.1080/14712598.2025.2536351.

    PMID: 40668062
  127. 127

    Managing the clinical heterogeneity of patients with Still's disease, from early diagnosis to timely treatment.

    Ruscitti P, Cantarini L, Ciccia F, et al.

    Autoimmunity reviews 2025; (24(10)):103880 doi:10.1016/j.autrev.2025.103880.

    PMID: 40684897
  128. 128

    Literature analysis and implication of biologic therapy for children with non-systemic juvenile idiopathic arthritis in real-world settings.

    Fung A, Yue X, Wigle PR, Guo JJ

    Intractable & rare diseases research 2025; (14(3)):162-174 doi:10.5582/irdr.2025.01035.

    PMID: 40904640
  129. 129

    The long-term follow up of patients with oligoarticular juvenile idiopathic arthritis: a single center experience.

    Aliyeva A, Adrovic A, Aslak F, et al.

    Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina 2025; (22(2)):299-303 doi:10.17392/1905-22-02.

    PMID: 41082757
  130. 130

    Spatial transcriptomics reveals immune-stromal crosstalk within the synovium of patients with juvenile idiopathic arthritis.

    Inamo J, Fierkens R, Clay MR, et al.

    JCI insight 2026; (11(1)).

    PMID: 41269758
  131. 131

    Comparison of clinical practices during the transitional and young adult phases between patients with oligoarticular/polyarticular juvenile idiopathic arthritis and those with rheumatoid arthritis in Japan.

    Mori S, Shabana K, Matsui T, et al.

    Pediatric rheumatology online journal 2025; (23(1)):120 doi:10.1186/s12969-025-01164-6.

    PMID: 41286783
  132. 132

    Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registry.

    Ata EB, Kılıç L, Fırlatan Yazgan B, et al.

    Clinical rheumatology 2026; (45(2)):781-789 doi:10.1007/s10067-026-07938-x.

    PMID: 41533222
  133. 133

    Non-systemic Juvenile Idiopathic Arthritis: How do the provisional PRINTO criteria shape the classification?

    Yildiz M, Konte Kilic E, Aslan E, et al.

    The Journal of rheumatology 2026; doi:10.3899/jrheum.2025-0551.

    PMID: 41621940